Efficacy of Educational Intervention for Parents of Children With Asthma
31 de outubro de 2013 atualizado por: Blanca Nohemí Zamora Mendoza, Universidad Autonoma de San Luis Potosí
Efficacy of Educational Intervention for Parents of Children With Asthma in 4-11 Years and Their Impact on the Control Children as Measured by ACT. Randomized Controlled Clinical
Introduction.
Asthma is a chronic inflammatory disorder of the airways, identified by airflow obstruction.
Unfortunately only 2.4% of American asthmatics meet internationally recommended criteria for control.
The lack of knowledge in parents of asthmatic children has been a direct result of minimum or no control at all, so the educational programs need to be assessed in terms of improvement of the control.
Target.
To determine whether an educational intervention aimed at parents of asthmatic children 4 to 11 years improved clinical control measured by Test Childhood Asthma Control.
Material and Methods.
Randomized controlled clinical trial in 42 patients randomly divided into two groups that were evaluated in the same time knowledge and control of asthma, a measurement was performed at baseline and monthly for nine months.
The experimental group attended an educational intervention for individual reinforcements through this period, the control group was only monitored
Visão geral do estudo
Status
Concluído
Condições
Intervenção / Tratamento
Descrição detalhada
- Recruitment of patients that attended hospital's emergency gate due to asthma issues, and phone calls to regular physicians patients.
- Once recruited all parents of patients were asked to participate in the study where their children will be evaluated on an asthma control and asked informed consent
- The clinical history, spirometry and / or basal peak flow Diagnostic concordance
- With the collected data was performed a database clinical history, ACT score, FEV1 and PEF, results of each patient and personal data for future location, the base was used for the concordance of diagnosis.
- Once the sample that met the selection criteria were formed experimental and control groups at random using "R Project Statistical Computing" 2.12.2 version performed by the statistical
- The experimental group was invited to participate in educational sessions two hours at week in just one month and monthly individual reinforcements through the evaluation period.
- Educational sessions were based on the Global Initiative for Asthma (GINA), Guía Española para el Manejo del Asma (GEMA) And Concenso Mexicano de Asma.
- Those measurements were performed by an external partner or educators or the attending physician performed to avoid biased results.
The monthly ACT and peak flow of the attending physician were blinded
variables:
- educational intervention, with and without intervention
- asthma control: measured by infant ACT
- time: 0 to 9 months
- sex: female or male
- Age: 4 to 11 years
Tipo de estudo
Intervencional
Inscrição (Real)
42
Estágio
- Não aplicável
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
4 anos a 11 anos (Filho)
Aceita Voluntários Saudáveis
Não
Gêneros Elegíveis para o Estudo
Tudo
Descrição
Eligibility Criteria
- Children 4-11 years with diagnosed asthma with parents attending the outpatient pediatric pneumology and pediatric emergency because of acute asthma in General Hospital de Soledad.
- Patients with a baseline score less than 27 points in childhood ACT
- Patients with Government Health Insurance. (to ensure access to medication and medical care)
- Parents who can read and write
- Parents willing and able to participate
- Parents who do not belong or have been part of an educational program on asthma by asthma clinic.
Exclusion Criteria
- Parents with children having other comorbidities that prevent or hinder proper control of asthma, such as Cerebral Palsy, (PCI) psychomotor retardation, psychiatric Sd. Down, congenital malformations, which alter the chest wall, obesity, nasal polyp.
Elimination criteria
- Parents who fail to attend 50% of the sessions given (since it does not allow parents to acquire sufficient knowledge to significantly improve the control of asthma as GEMA educational guidance)
- Patients and parents who decide not to continue in the project.
- Patients who develop pulmonary comorbidities over a month of evolution and lung tissue affecting significantly, as syncytial respiratory virus, pneumonia, tuberculosis, and asthma control difficulties.
- Patients who leave or do not take the prescribed treatment by physician for a month.
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Sem intervenção: treatment and routine counseling
Parents attend regular consultation and receive regular medical guidance
|
educational sessions once a week two hours for a month and later educational reinforcement and monitoring asthma control monthly for nine months
Outros nomes:
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Prazo |
|---|---|
|
asthma control
Prazo: 9 months
|
9 months
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Blanca ZM master, Universidad Autónoma de San Luis Potosí México
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo
1 de fevereiro de 2012
Conclusão Primária (Real)
1 de outubro de 2012
Conclusão do estudo (Real)
1 de outubro de 2013
Datas de inscrição no estudo
Enviado pela primeira vez
30 de maio de 2013
Enviado pela primeira vez que atendeu aos critérios de CQ
31 de outubro de 2013
Primeira postagem (Estimativa)
8 de novembro de 2013
Atualizações de registro de estudo
Última Atualização Postada (Estimativa)
8 de novembro de 2013
Última atualização enviada que atendeu aos critérios de controle de qualidade
31 de outubro de 2013
Última verificação
1 de outubro de 2013
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- A-001
- UASLP-001 (Identificador de registro: UASLP-001)
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .